Mar 25, 2014· Comment from Consumer Healthcare Products Association· FDA-2013-N-0500-0029
Please see the attached comments from the Consumer Healthcare Products Association re: FDA's proposed rule; supplemental applications proposing labeling changes for approved drugs and biological products [Docket No. FDA-2013-N-0500]